Overview of the global biosensor market for non-clinical applications
The global biosensor market for non-clinical applications is anticipated to witness impressive growth and will post a staggering CAGR of more than 11% over the forecast period. Nanotechnology is an emerging technology that involves the study, creation, manipulation, and use of materials, devices, and systems with dimensions lesser than 100 nm. It also plays a crucial role in the development of biosensors. Nanomaterials not only help introduce several new signal transduction technologies in biosensors but also improve the sensitivity and performance of biosensors. The development of nanotech has resulted in an increase in the applications of nanomaterials in biosensors to a large extent. For example, nanomaterials-based biosensors can significantly increase the sensitivity and specificity of biomolecule detection, detect and manipulate atoms and molecules, and also show potential in applications such as biomolecular recognition, pathogenic diagnosis, and environment monitoring. Moreover, various kinds of nanomaterials, including carbon nanotubes, gold nanoparticles, and quantum dots are being increasingly used in biosensors due to their unique chemical, physical, mechanical, magnetic, and optical properties. The is anticipated to result in the manufacturing of better and more efficient biosensors, leading to their augmented adoption in the coming years.
The integration of biosensors with social networks is one of the significant trends driving this market’s growth during the predicted period. Health and other fitness-related statistics obtained with the help of biosensors become more relevant when the data can be compared with those of others. The Biogram app, which was launched in 2015, allows users to stamp their heart rate data on photos before sharing them on Instagram. Similar options are available for different types of fitness wearables that enable users to measure and compare their vital statistics to those of their peers and friends. Moreover, social network-based biosensors help patients keep a track of their daily drug dosage patterns. When a user gets in contact with a pill bottle, the biosensor patch on the bottle sends a signal to the user’s phone, which stores the data in the cloud. This data can be used by healthcare professionals to monitor the health of their patients, and is likely to revolutionize the overall healthcare market in the near future.
Segmentation by technology and analysis of the biosensors market for non-clinical applications
Military and defense
Food and beverage
During 2015, the healthcare sector dominated the market and accounted for more than 44% of the market share in terms of revenue. The rising occurrence of lifestyle-related diseases and increasing health awareness among different types of consumers such as athletes, IT professionals, and old-age people will drive this segment’s growth over the next four years.
Geographical segmentation and analysis of the biosensors market for non-clinical applications
In terms of geography, North America dominated the market and is expected to reach more than USD 4 billion by 2020. North America has always been a pioneer in the adoption of new technologies and their implementation for a wide array of applications. Moreover, this region is home to a large number of notable OEMs for fitness trackers and wearables such as Apple, FitBit, Motorola, Jawbone, and Nike. These factors will contribute to the expansion of this market in North Americas until the end of 2020.
Competitive landscape and key vendors
The global biosensors market for non-clinical applications is highly competitive owing to the presence of a large number of well-established vendors. The market is attracting several new companies due to the rapid adoption and increasing demand of biosensors for various applications. Players in the market are constantly looking for ways to enhance their market presence by focusing on the implementation of various new technology and M&A activities.
Key vendors in this market are -
Other prominent vendors in the market are 3M, Abbott Laboratories, Analog Devices, Bayer Healthcare Beckman Coulter, Becton, Dickinson and Company, Biacore International, Bio-Rad Laboratories, Biosensors International Group, Cambridge Life Sciences, DSM Biomedical, EMD Millipore, LifeScan, Nova Biomedical, Roche, and Siemens.
Key questions answered in the report include
What will the market size and the growth rate be in 2020?
What are the key factors driving the global biosensors market for non-clinical applications?
What are the key market trends impacting the growth of the global biosensors market for non-clinical applications?
What are the challenges to market growth?
Who are the key vendors in the global biosensors market for non-clinical applications?
What are the market opportunities and threats faced by the vendors in the global biosensors market for non-clinical applications?
What are the trending factors influencing the market shares of APAC, Europe, North America, and ROW?
What are the key outcomes of the five forces analysis of the global biosensors market for non-clinical applications?
Technavio also offers customization on reports based on specific client requirement.